Man Group’s Nutex Health NUTX Stock Holding History

Man Group’s Portfolio NUTX Stock Details NUTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-247	Closed	-$15.6K	–	2084
2023 Q2	$15.6K	Buy	+247	New	+$21.2K	﹤0.01%	1932

Other funds holding NUTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SWM

Scissortail Wealth Management Tulsa, Oklahoma $498M AUM 20.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Man Group's NUTX Position: Q3 2023 in Review

Man Group sold out of Nutex Health (NUTX) in Q3 2023, closing a stake of 247 shares — an estimated $15.6K sold.

Man Group first reported a position in NUTX in Q2 2023 and held it in 1 quarter. The position peaked at $15.6K in Q2 2023. 59 funds tracked by Wall St. Rank hold NUTX as of Q3 2023.

Man Group reported no remaining Nutex Health position as of Q3 2023 after selling out during the quarter.
Man Group sold 247 Nutex Health shares in Q3 2023, an estimated $15.6K.
Man Group first reported a position in Nutex Health in Q2 2023 and held it in 1 quarter.
Man Group's Nutex Health position peaked at $15.6K in Q2 2023.
59 funds tracked by Wall St. Rank held Nutex Health as of Q3 2023.

Based on Man Group's 13F filing for Q3 2023, filed 14 Nov 2023.